Brain Vision Technology Competitors

EMOTIV is a bioinformatics company advancing understanding of the human brain using electroencephalography (EEG). Our mission is to empower individuals to understand their own brain and accelerate brain research globally. Applications for the EMOTIV technology and interface span an incredible variety of industries - from gaming to interactive television, everyday computer interactions, hands-free control system, smart adaptive environments, art, accessibility design, market research, psychology, medicine, robotics, automotive, transport safety, defense and security. EMOTIV is a recognized pioneer and market leader in this field. Our products have won numerous international awards including the Red Dot Award, AutoVision Innovations Award, Australian International Design Awards, Australian Engineering Excellence Awards and Edison Awards. Our community of developers and researchers span over 120 countries.

CureMetrix is committed to the advancement of technology that improves disease detection and survival rates worldwide. Our AI-based products and research are focused on leveraging artificial intelligence and deep learning to develop the next generation of medical image analysis technology that radiologists and patients can confidently rely on. Today, our powerful image analysis platform is an adjunct, precision tool for mammography. Our goal is to equip radiologists with the objective, data-driven answers they need to support patients and their healthcare team as they make decisions about their health. At CureMetrix, we believe that providing radiologists with the most advanced technology to support their evaluation of mammograms will lead to improved clinical outcomes, reduced healthcare costs, and increased assurance that patients are getting the highest standard of care available from screening. Over the last 10 years since our founding in 2014, we have focused on building products with extremely high efficacy that are easy to install, operate within existing clinical workflows, and minimize extra steps from radiologists and patients. CureMetrix has partnered with practicing radiologists, cardiologists, and esteemed institutions around the world to collect over 5 million images to train and validate our algorithms. From breast cancer to heart disease to kidney disease we believe that AI can be used to improve outcomes for patients and extend the impact and value of screening programs globally.

g.tec medical engineering was founded in 1999 as a spin-off from the Technical University in Graz, Austria. Christoph Guger and Günter Edlinger developed the first commercial Brain-Computer Interface (BCI) system at this time. As a producer of state-of-the-art invasive and non-invasive BCI systems with sales and research partners worldwide, g.tec is a leader in the fields of BCI, medical devices, neurotechnology, neurorehabilitation and biosignal processing with branches in Schiedlberg and Graz (Austria), Barcelona (Spain), and New York (USA). g.tec’s BCI systems are realized by four major principles: slow waves, steady-state visual evoked potentials (SSVEP), motor imagery (MI) and evoked potentials (EP). The hardware and software of g.tec’s BCI technology can be used in clinical environments or for research purposes such as the analysis of the brain, heart or muscle activity, brain assessments of severe brain injuries and disorders of consciousness, motor rehabilitation after stroke, neuromarketing, deep brain stimulation, brain mapping, neuro prosthesis, communication, painting and closed-loop invasive and non-invasive BCI experiments. g.tec’s products and research activities have been widely described in peer-reviewed research publications, demonstrating the quality of tools and methods and the unlimited possibilities and the impact of brain-computer interface technology. Read more about g.tec’s worldwide BCI research, distributors and products online: www.gtec.at